Privia Health Group, Inc. (PRVA)
| Market Cap | 3.11B |
| Revenue (ttm) | 2.12B |
| Net Income (ttm) | 22.92M |
| Shares Out | 125.62M |
| EPS (ttm) | 0.18 |
| PE Ratio | 136.95 |
| Forward PE | 70.38 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 850,051 |
| Open | 24.47 |
| Previous Close | 24.41 |
| Day's Range | 24.25 - 24.89 |
| 52-Week Range | 18.77 - 26.51 |
| Beta | 0.87 |
| Analysts | Buy |
| Price Target | 31.17 (+25.81%) |
| Earnings Date | May 7, 2026 |
About PRVA
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates acc... [Read more]
Financial Performance
In 2025, Privia Health Group's revenue was $2.12 billion, an increase of 22.26% compared to the previous year's $1.74 billion. Earnings were $22.92 million, an increase of 59.33%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for PRVA stock is "Buy." The 12-month stock price target is $31.17, which is an increase of 25.81% from the latest price.
News
Privia Health to Report First Quarter 2026 Results on Thursday, May 7
ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 befo...
Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence
ARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a...
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
WILMINGTON, Del.--(BUSINESS WIRE)-- #AIinHealthcare--Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia He...
Privia Health Group Earnings Call Transcript: Q4 2025
Strong 2025 results exceeded guidance, with 16.9% Practice Collections growth and 38.8% higher Adjusted EBITDA. 2026 guidance projects continued double-digit growth, robust cash flow, and disciplined capital deployment, supported by recent acquisitions and technology investments.
Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results
All 2025 Operating and Financial Metrics At or Above High End of Guidance Ranges Full-year 2025 Net Income +59.3% from 2024 Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024 Full-year...
Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26
ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ...
Privia Health Group Earnings Call Transcript: Q3 2025
Q3 2025 saw robust growth in practice collections, adjusted EBITDA, and attributed lives, driven by strong value-based care performance and new provider additions. The company raised its 2025 outlook and is expanding through a major ACO acquisition, maintaining strong cash flow and financial flexibility.
Privia Health Reports Third Quarter 2025 Financial Results
Privia Health Reports Very Strong Q3 and YTD Results Across the Business; FY'25 Guidance Raised Above High End for All Key Operating and Financial Metrics
Privia Health to Report Third Quarter 2025 Results on Thursday, November 6
ARLINGTON, Va., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods end...
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care
Privia Health Group, Inc. PRVA on Tuesday agreed to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. EVH.
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path. Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to ...
Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business f...
Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase
– Mid-Atlantic ACO Realized Highest Savings Rate of All ACOs with 40,000+ Attributed Lives – Company Increases Adjusted EBITDA Guidance for Full-Year 2025 ARLINGTON, Va., Aug. 28, 2025 (GLOBE NEWSWIRE...
Privia Health Group Earnings Call Transcript: Q2 2025
Q2 2025 saw robust provider and attributed lives growth, record practice collections, and a 31.6% increase in adjusted EBITDA. Guidance for 2025 was raised above initial ranges, with strong cash flow and continued expansion into new markets like Arizona.
Privia Health Reports Second Quarter 2025 Financial Results
Strong Performance Across Key Metrics; Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution, Adj EBITDA
Privia Health to Report Second Quarter 2025 Results on Thursday, August 7
ARLINGTON, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods end...
Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors
Berberian brings significant technology leadership and cybersecurity expertise Berberian brings significant technology leadership and cybersecurity expertise
Privia Health Group Earnings Call Transcript: Q1 2025
Strong Q1 2025 results featured double-digit growth in providers, attributed lives, and collections, with adjusted EBITDA up 35%. Expansion into Arizona via a $95M IMS acquisition is expected to be EBITDA positive in Q4 and drive further growth.
Privia Health Reports First Quarter 2025 Financial Results
Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchange...
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings...
Privia Health Group Earnings Call Transcript: Q4 2024
Delivered strong 2024 results, exceeding guidance on all key metrics with robust provider and attributed lives growth, record free cash flow, and margin expansion. 2025 guidance anticipates continued growth despite Medicare Advantage headwinds, with prudent assumptions for shared savings and capital deployment.
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Op...
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods end...
Privia Health Group Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025
A primary care-centric network operating in 14 states, the business leverages a scalable, tech-enabled model to drive value-based care, strong financial performance, and provider autonomy. Record provider adds and robust cash flow support expansion, with 2025 EBITDA growth expected above 20%.
Privia Health Group Earnings Call Transcript: Q3 2024
Q3 2024 saw strong growth in providers, attributed lives, and financial metrics, with adjusted EBITDA up 25.8% year-over-year and free cash flow conversion exceeding expectations. Expansion into Indiana and robust performance in value-based care underpin raised 2024 guidance.